GenSight Biologics S.A.

SIGHT.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-€14-€26-€28-€29
Dep. & Amort.€1€3€1€1
Deferred Tax€0€0€0€0
Stock-Based Comp.€1€1-€3€5
Change in WC€1€2-€4€5
Other Non-Cash-€1-€5€0€1
Operating Cash Flow-€13-€25-€34-€17
Investing Activities
PP&E Inv.€0-€0-€0-€0
Net Acquisitions€0€0€0€0
Inv. Purchases€0€0€0€0
Inv. Sales/Matur.€0€0€0€0
Other Inv. Act.€0€0€0€0
Investing Cash Flow€0€0€0-€0
Financing Activities
Debt Repay.-€2€13€3-€4
Stock Issued€17€4€0€0
Stock Repurch.-€0-€0-€0-€0
Dividends Paid€0€0€0€0
Other Fin. Act.-€1-€1-€3€27
Financing Cash Flow€14€16€0€24
Forex Effect-€0€0-€0-€0
Net Chg. in Cash€0-€8-€34€6
Supplemental Information
Beg. Cash€2€11€44€38
End Cash€2€2€11€44
Free Cash Flow-€13-€25-€34-€17
GenSight Biologics S.A. (SIGHT.PA) Financial Statements & Key Stats | AlphaPilot